SUMMARY The haemodynamic effects of dobutamine (2.5 to 10 ug/min per kg) were determined in 5 patients without cardiac failure who were undergoing cardiac catheterisation for suspected coronary disease. Myocardial blood flow was determined by the coronary sinus thermodilution technique. Data were compared with those from two groups of 5 patients who received dopamine (4-8 ,ug/min per kg) and isoprenaline (0.005-0.025 ,ug/min per kg). Each drug was given in a lower and a higher dose, and all increased mean cardiac index (dobutamine, 18% and 39%; dopamine, 11% and 23%; isoprenaline, 15% and 44%). These increases were associated with significant increases in mean myocardial oxygen consumption (dobutamine, 38% and 61%; dopamine, 25% and 62%; isoprenaline, 20% and 45%). Mean myocardial blood flow was increased by each drug but mean myocardial oxygen extraction was decreased by isoprenaline, was increased by dopamine, and was unchanged by dobutamine. Each inotropic agent has a similar effect on myocardial oxygen consumption, but isoprenaline has a direct coronary vasodilator action while dopamine has a coronary vasoconstrictor action. Dobutamine has no direct effect upon coronary vascular tone.
Dobutamine is a new inotropic agent which has been shown to be effective in improving left ventricular function in patients with congestive heart failure (Akhtar et al., 1975; Beregovich et al., 1975; Leier et al., 1977) . Dopamine, another inotropic sympathomimetic amine, also improves left ventricular function in patients with congestive heart failure (Loeb et al., 1971; Holzer et al., 1973; Beregovich et al., 1974) .
In the selection of an inotropic drug for use in patients with acute myocardial infarction an important consideration is its possible effect on infarct size. Inotropic drugs have a potential for increasing myocardial oxygen consumption (Braunwald, 1971) , thereby increasing oxygen demand in excess of supply with a consequent increase in infarct size (Maroko et al., 1971; Maroko and Braunwald, 1973) . Such drugs may also increase myocardial ischaemic injury through a primary effect on the coronary circulation. For example, isoprenaline has been shown to increase myocardial ischaemia in dogs through a 'coronary steal' effect whereby blood is shunted away from ischaemic areas by dilatation of adjacent resistance arterioles in normal myocardium (Sharma et al., 1971; McClenathan et al., 1977) .
Received for publication 20 June 1978 Conversely, a coronary vasoconstrictor effect may increase ischaemic injury by reducing coronary flow relative to myocardial oxygen demand.
This study was performed, therefore, to determine the haemodynamic effects of dobutamine with special reference to its effects on coronary dynamics, and to compare these effects with those of dopamine and isoprenaline.
Patients and methods
Fifteen patients without congestive heart failure, undergoing cardiac catheterisation for suspected coronary artery disease, were studied. Informed consent was obtained in all cases. All drugs were withdrawn 48 hours before the study, except for 15 mg diazepam given as premedication.
One group of 5 patients received isoprenaline, one group of 5 received dobutamine, and another received dopamine. Drug doses were selected according to the individual's response. An attempt was made to match increases in cardiac output for the 3 drugs.
Patient data are presented in Table 1 together with drug doses for individual patients.
Pressures were measured using Bell and Howell transducers set for zero at mid-chest level, and 43 recorded on a Mingograf 82 recorder at paper speeds of 25 and 50 mm/s. Systemic arterial pressure was recorded using a Desilets Hoffman cannula placed in the femoral artery. Pulmonary arterial and pulmonary artery wedge pressures were recorded using a flow-directed thermodilution catheter advanced to the pulmonary artery from the femoral vein. Cardiac output was measured by the thermodilution technique (Ganz and Swan, 1972 ) using a Waters computer.
Myocardial blood flow was determined by the method described by Ganz et al. (1971) . To make this determination a special catheter was positioned in the coronary sinus via a left antecubital vein. Coronary sinus flow was determined by a continuous thermodilution technique using the formula described below. Since the coronary sinus drains nearly all of the left ventricular myocardium (Hood, 1968) , coronary sinus flow may be assumed to represent left ventricular myocardial blood flow. In o -der to include the contribution to coronary sinus flow of the posterior interventricular vein, the catheter was first positioned high in the great cardiac vein and was then slowly withdrawn toward the orifice of the coronary sinus. The point at which there was a sudden and distinct increase in flow (indicated by an increase in the temperature of the mixture of blood and injectate recorded by the downstream thermnistor as it passed the junction of John Stephens, Harold Ead, and Roworth Spurrell the posterior interventricular vein and coronary sinus) determined the position at which flow was measured. Experience in this laboratory has shown that coronary sinus flow accurately represents myocardial blood flow over a wide range of flows in patients with and without coronary artery disease (Stephens et al., 1978) .
The coronary sinus catheter was used to measure coronary sinus pressure.
Mean pressures were obtained by electronic integration. Blood oxygen content was measured by the fuel-cell technique (Lex 02 Con).
Lead II of the electrocardiogram was recorded for heart rate measurement and for observation of possible ST-T changes.
PROCEDURE
After left ventriculography and coronary arteriography (Judkins' technique) 30 minutes were allowed for recovery from the haemodynamic effects of contrast media (Mullins et al., 1972) .
Control recordings of heart rate, pressures, and coronary sinus flow were made. Cardiac output determinations were made in triplicate. Simultaneous systemic arterial and coronary sinus blood samples were withdrawn for oxygen content measurement.
A lower dose followed by a higher dose of drug was infused for periods of 10 minutes, measurements being repeated during each period.
There were no complications from the study. No patient complained of angina and no ST-T changes were observed on the electrocardiogram during the periods of drug infusion.
CALCULATIONS
Systemic vascular resistance, coronary vascular resistance, and left ventricular stroke work index were calculated using standard formulae. Myocardial oxygen consumption (ml/min) = product of myocardial blood flow (coronary sinus flow) and the coronary arteriovenous oxygen content difference (AV02 diff.). Myocardial oxygen extraction (per cent) = AV02 diff./arterial oxygen content x 100. 24+2-4** 29+ 3-2*** Myocardial oxygen extraction (%) 66+4-2 59+4-2 56+3-6 Coronary vascular resistance (dynes s cm-5) (x 10-3) 45+ 3-3 35+ 4-3*** 28+3-8****.
Coronary sinus mean pressure (mmHg) 5+1-0 3+0 9 5+ 0-8 ** P <0-02; *** P <0 01; **** P <0 001.
All values are shown as mean + SEM for 5 patients.
Results Dobutamine (Table 3) Mean heart rate increased slightly (3% and 17%)
CINEANGIOGRAPHIC DATA but these changes were not significant. There were Left ventriculography showed all patients to have a dose-related increases in mean cardiac index (18% normal ejection fraction. and 39%), though the further increase with the Coronary arteriographic findings are shown in higher dose was not statistically significant. Changes Table 1. in mean stroke volume index reflected this pattern (14% and 22%). Systemic arterial mean pressure SYSTEMIC HAEMODYNAMIC DATA increased significantly (mean 23% and 26%). There were no significant changes in mean values for pulIsoprenaline (Table 2) monary artery wedge mean pressure or systemic There were dose-related increases in mean heart vascular resistance. Mean left ventricular stroke rate (8% and 28%) and cardiac index (15% and work index increased significantly (22% and 53%). 44%). Though mean stroke volume increased (6% and 15%) these changes were not significant. Mean Dopamine (Table 4) values for pulmonary artery wedge mean pressure Dopamine produced no significant change in mean and systemic arterial mean pressure were un-heart rate. Mean cardiac index increased (11% and changed. Mean systemic vascular resistance fell 23%), but as with dobutamine the increase with the significantly (13% and 30%). Mean left ventricular higher dose was not statistically significant. Mean stroke work index increased (6% and 17%) but stroke volume index increased significantly (10% these changes were not statistically significant. and 18%). Mean values for systemic arterial mean 20+ 3-2* 26+ 3-0**** Myocardial oxygen extraction (%) 60+ 2-6 65+ 3-6 70+ 2-9*** Coronary vascular resistance (dynes s cm-5) (x 10-3) 60+4-7 49+ 6-0 42+ 3-8*** Coronary sinus mean pressure (mmHg) 5+ 0-6 5+ 0-8 6+ 11
*P <005; **P <0-02; ***P <0-01; ****P <0-001.
pressure and pulmonary artery wedge mean pressure were unchanged. Mean systemic vascular resistance fell (18% and 22%). Mean left ventricular stroke work index increased (5% and 21%) but these changes were not statistically significant.
CORONARY HAEMODYNAMIC DATA Isoprenaline (Table 2) There was a dose-related increase in coronary sinus flow in all patients (Fig. 2) , mean values increased (33% and 68%). Myocardial oxygen extraction fell conspicuously in 3 patients, fell slightly with the higher dose in 1, and remained unchanged in 1 (Fig. 3) ; the fall in mean values (11% and 15%) did not quite reach statistical significance. There was a significant dose-related increase in mean myocardial oxygen consumption (20% and 45%). Mean coronary vascular resistance fell significantly (22% and 38%). Mean coronary sinus pressure was unchanged.
Dobutamine (Table 3) Coronary sinus flow increased in 4 patients and fell slightly in 1 for the lower dose. The higher dose produced further increases in 3 patients (Fig. 2) ; mean values increased by 29 and 51 per cent. Myocardial oxygen extraction did not change significantly (Fig. 3 ). There were significant dose-related increases in mean myocardial oxygen consumption (38% and 61%). Mean coronary vascular resistance fell (2% and 20%) but the changes did not achieve statistical significance. Coronary sinus mean pressure was unchanged.
Dopamine (Table 4) The pattern of changes in coronary sinus flow was similar to that found for dobutamine (Fig. 2) Statistical analysis showed no significant difference between the changes in myocardial oxygen consumption and coronary sinus flow for the three groups. However, the decrease in myocardial oxygen extraction with isoprenaline was significant compared with the other two groups, myocardial oxygen extraction being unchanged with dobutamine, and increased with dopamine.
Discussion
The increase in cardiac output produced by isoprenaline was achieved primarily by an increase in heart rate rather than stroke volume. In contrast, dobutamine and dopamine increased cardiac output principally by increasing stroke volume, there being little change in heart rate. The higher dose of dobutamine and dopamine did not in all cases increase cardiac output further; this may be related to a plateau in the inotropic effect, in the absence of an increase in heart rate or, as in some patients, with a slight decrease in heart rate possibly the result of a reflex vagal effect. Isoprenaline and dopamine produced significant falls in systemic vascular resistance, mean systemic arterial pressure being unchanged. Dobutamine, however, caused an increase in systemic arterial mean pressure with no change in systemic vascular resistance. This was an unexpected finding since dobutamine has been found to have little alpha-adrenergic effect on the peripheral vasculature (Tuttle and Mills, 1975) . Previous studies in patients with congestive heart failure have shown systemic arterial pressure to be unchanged by dobutamine, though Loeb et al. (1975) (Goldberg, 1972) .
In this study the 3 sympathomimetic amines produced similar substantial dose-related increases in myocardial oxygen consumption. Since all 3 drugs have inotropic properties (Tuttle and Mills, 1975) , augmented myocardial contractility was a common factor in producing such increases (Braunwald, 1971) . Since heart rate is an important determinant of myocardial oxygen consumption (Sarnoff et al., 1958) , the increase in heart rate must have been an important additional reason for the observed increase in myocardial oxygen consumption produced by isoprenaline. However, this increase may have been counteracted by the peripheral vasodilator effect of isoprenaline, limiting the increase in systemic arterial pressure (Braunwald, 1971) . The pressor effect of dobutamine and the slight increase in heart rate may have contributed to the increased myocardial oxygen consumption by increasing left ventricular afterload. The comparable increases in myocardial oxygen consumption produced by dopamine are more difficult to explain. Since indices of myocardial contractility were not measured in this study, a comparison of the contribution of the increases incontractility produced by the 3 inotropic agents to increases in myocardial oxygen consumption is not possible. However, it is conceivable that dopamine in the doses used produced greater augmentation in myocardial contractility than dobutamine or isoprenaline, accounting for its comparable effects on myocardial oxygen consumption.
Although the 3 drugs produced similar increases in myocardial oxygen consumption there were differences in their effects on the global myocardial oxygen demand/supply relation. Increased myocardial oxygen demand is met principally by an increase in myocardial blood flow, probably through autoregulation (Berne, 1964) , myocardial oxygen extraction remaining constant (Katz and Feinberg, 1958; Stephens et al., 1978) . Changes in myocardial oxygen extraction produced by a drug may therefore be taken as evidence that the drug has a direct effect on the smooth muscle of the coronary vessels, distinct from its indirect effect on flow induced by changes in myocardial metabolic requirements (Gregg and Sabiston, 1956) .
In the present study, dopamine increased Jrohn Stephens, Harold Ead, and Roworth Spurrell coronary sinus flow and decreased coronary vascular resistance, associated with a significant increase in myocardial oxygen extraction. These observations suggest that while coronary vasodilatation occurred in response to augmented myocardial oxygen demand induced by dopamine, this response was attenuated by a direct coronary vasoconstrictor effect of the drug (Berne, 1958) . Dopamine therefore adversely affected the balance between oxygen demand and supply for the myocardium as a whole. Isoprenaline also increased coronary sinus flow. However, compared with dopamine, there was an opposite effect upon myocardial oxygen extraction, suggesting that isoprenaline increased myocardial blood flow in excess of that required to meet increased myocardial oxygen demand and that the drug therefore has a direct coronary vasodilator action. Because dobutamine had no significant effect upon myocardial oxygen extraction, it may be concluded that the observed increases in coronary sinus flow were the result of augmented myocardial oxygen demand alone, and that dobutamine has no significant direct effect upon the coronary vasculature.
A coronary vasoconstrictor effect of dopamine has not previously been described, though a recent report (Wilkes et al., 1976 ) described a reduction in coronary sinus oxyhaemoglobin saturation in dogs after dopamine infusion, despite an increase in myocardial blood flow. These authors, however, ascribed this finding to inadequate metabolic autoregulation. Brooks et al. (1969) found that dopamine increased myocardial blood flow in the dog commensurate with increases in myocardial oxygen consumption. Crexells et al. (1973) studied the haemodynamic and cardiac metabolic effects of dopamine in 10 patients with coronary disease. Though myocardial blood flow was not measured, these authors inferred that dopamine did not increase myocardial oxygen consumption as they found no significant change in the tension-time index. Furthermore, since there was no significant shift of myocardial lactate extraction to production, it was concluded that dopamine had no potential for increasing myocardial hypoxia. It is of interest to note, however, that in 9 of their 10 patients coronary sinus Po2 fell slightly, while in 2 myocardial lactate extraction shifted to production.
The conclusion from the present study that dopamine has a coronary vasoconstrictor effect is supported by certain theoretical considerations. The coronary arterial vasculature of the dog has been shown to possess alpha and beta-adrenergic receptors (Gaal et al., 1966) . Since dopamine acts by releasing noradrenaline from myocardial storage sites (Tuttle and Mills, 1975) , it has the potential to act indirectly on the coronary alpha-adrenergic receptors through the release of noradrenaline, thereby causing coronary vasoconstriction. This suggestion is substantiated by the reported coronary vasoconstrictor effect of noradrenaline in the dog (Berne, 1958) and in man (Yurchak et al., 1964) . In contrast, isoprenaline, because of its powerful beta-adrenergic effects, would be expected to dilate coronary arterial vessels. This effect has been reported in previous studies (Lewis et al., 1961; Greenfield et al., 1972) . Tuttle and Mills (1975) A major assumption in the interpretation of the results of the present study is that the presence and degree of coronary artery stenoses did not influence the observed changes in coronary sinus flow. Reports from this (Stephens et al., 1978) and other laboratories have shown that large increases in coronary sinus flow can occur despite the presence of coronary artery disease. Furthermore, incremental increases in coronary sinus flow occur during successive increases of heart rate by atrial pacing up to the development of angina in patients with coronary disease. Such changes are identical to those found in patients with normal coronary arteries . Since none of the patients in the present study developed angina during drug administration, it is unlikely that observed changes in coronary sinus flow were significantly modified by mechanical obstruction to flow by coronary disease. Further, the incidence and degree of coronary disease was roughly similar for the 3 patient groups, providing further evidence that differences in changes in coronary sinus flow relative to changes in myocardial oxygen extraction for the 3 drugs could be ascribed solely to differences in drug-induced changes in coronary arterial tone.
The results of this study may have clinical relevance with regard to patients with acute myocardial infarction. If dopamine causes coronary vasoconstriction when used in such patients, it may exacerbate the imbalance between oxygen demand and supply in ischaemic zones of the myocardium, thereby increasing infarct size. On the other hand, isoprenaline may exert its deleterious effect in patients with acute myocardial infarction (Mueller et al., 1972) in part through a coronary vasodilator effect, thereby causing 'coronary steal'.
